United States Cardiac Surgery and Heart Valve Devices Procedure Numbers Report 2017-2018

DUBLIN, Dec. 13, 2017 /PRNewswire/ --

The "US Procedure Numbers for Cardiac Surgery and Heart Valve Devices 2018 - MedPro" report has been added to Research and Markets' offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Recently, minimally invasive cardiac surgery has started to gain popularity among surgeons and patients. Minimally invasive procedures allow for reduced hospitalization and less scarring. The growth of the minimally invasive procedures comes from the cannibalization of the open-heart surgery procedures. Currently, many types of minimally invasive procedures do not have FDA approval. As more products get FDA approved, the minimally invasive procedures are expected to grow at a much higher rate and cause the open-heart procedures to decline.

Cardiac surgery and heart valve procedures accounts for a large array of procedures. Generally, cardiac surgery is done through open heart surgery where a surgeon opens the chest and heart. For heart valves, the surgeon could replace or repair the damaged heart valve. Another common cardiac surgery procedure would be coronary artery bypass grafting where a harvested vein is grafted onto the heart to bypass blocked arteries. This procedure can be done on-pump, where a cardioplegic solution is sued to stop the heart and the patient is put on a heart-lung machine, or off-pump, also known as beating heart surgery.

Key Topics Covered:

Executive Summary

1. Research Methodology

2. Disease Overview
2.1 Basic Anatomy

3. Procedure Numbers
3.1 Introduction
3.2 Cardiac Surgery And Heart Valve Procedures
3.3 Surgical Heart Valve Replacement Procedures
3.4 Annuloplasty Repair Procedures
3.5 Transcatheter Mitral Heart Valve Repair Procedures
3.6 Transcatheter Aortic Heart Valve Replacement Procedures
3.7 Cabg Procedures
3.8 Transmyocardial Revascularization Procedures
3.9 Ventricular Assist Device Procedures
3.10 Intra-Aortic Balloon Pump Procedures
3.11 Temporary Artificial Heart Procedures
3.12 Remote Hemodynamic Monitoring Procedures
3.13 Patent Foramen Ovale Closure Procedures
3.14 Septal Defect Closure Procedures
3.15 Left Atrial Appendage Closure Procedures

Companies Mentioned

    --  Edwards Lifesciences
    --  St. Jude Medical
    --  Medtronic
    --  Maquet
    --  Abiomed
    --  HeartWare Inc.
    --  Sorin Group
    --  Terumo
    --  Abbott Laboratories
    --  Teleflex Medical
    --  Cardiac Assist
    --  AtriCure
    --  W.L. Gore
    --  SynCardia
    --  Boston Scientific
    --  Cryolife
    --  Berlin Heart
    --  Cardica
    --  Chase Medical
    --  Genesee Biomedical
    --  Karl Storz
    --  LifeNet Health
    --  Microline Surgical
    --  Novadaq
    --  On-X
    --  Saphena Medical
    --  SentreHeart
    --  Vitalitec

For more information about this report visit https://www.researchandmarkets.com/research/fz4kcs/united_states?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/united-states-cardiac-surgery-and-heart-valve-devices-procedure-numbers-report-2017-2018-300570866.html

SOURCE Research and Markets